Skip to content
Dx

ICD-10-CM 2027 diagnosis code

H59.313Postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure, bilateral

✓ Billable / specificCC — complication/comorbidity

H59.313 is a valid, billable ICD-10-CM code for postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure, bilateral. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Postproc hemor of eye and adnexa fol an opth procedure, bi

Code last changed in FY2017 (effective October 1, 2016). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About H59.313

H59.313 is the ICD-10-CM diagnosis code for postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure, bilateral. It belongs to category H59 (intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified), block H59 (intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within H59.31 (postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure), H59.313 is specifically for postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure, bilateral. Related codes cover right eye and adnexa following an ophthalmic procedure (H59.311), left eye and adnexa following an ophthalmic procedure (H59.312) and unspecified eye and adnexa following an ophthalmic procedure (H59.319).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 919 (Complications of Treatment with MCC, relative weight 1.763), DRG 920 (Complications of Treatment with CC, relative weight 0.9975) and DRG 921 (Complications of Treatment without CC/MCC, relative weight 0.6722), in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015, and changed in FY2017 (title revised).

Before ICD-10, this condition was coded in ICD-9-CM as 998.11 (hemorrhage complicating a procedure).

Notes that apply from higher levels

Instructions written at a parent level also apply to H59.313.

› From H59 Intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified
Excludes1
  • mechanical complication of intraocular lens (T85.2)
  • mechanical complication of other ocular prosthetic devices, implants and grafts (T85.3)
  • pseudophakia (Z96.1)
  • secondary cataracts (H26.4-)

Broader instructions also apply from Chapter 7: Diseases of the eye and adnexa.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 998.11Hemorrhage complicating a procedureapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • FY2017 (effective 10/1/2016): Title revised — was “Postprocedural hemorrhage and hematoma of eye and adnexa following an ophthalmic procedure, bilateral”

Common questions about H59.313

Is H59.313 billable?

Yes. H59.313 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can H59.313 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict H59.313 as a principal diagnosis.

Is H59.313 a CC or MCC?

H59.313 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does H59.313 group to?

H59.313 is used in the MS-DRG v44.0 logic for MS-DRG 919 (Complications of Treatment with MCC), MS-DRG 920 (Complications of Treatment with CC) and MS-DRG 921 (Complications of Treatment without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for H59.313?

The CMS General Equivalence Mappings map H59.313 to ICD-9-CM 998.11.